{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:06:06Z","timestamp":1792670766237,"version":"4.5.0"},"reference-count":28,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["37-2011-635"],"award-info":[{"award-number":["37-2011-635"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective: Targeting the glucagon-like peptide-1 receptor with radiolabeled exendin is a very promising method to noninvasively determine the \u03b2 cell mass in the pancreas, which is needed to unravel the pathophysiology of type 1 and type 2 diabetes. The present study aimed to explore the effects of both hyperglycemia and insulitis on the uptake of exendin in a spontaneous type 1 diabetes mouse model, nonobese diabetic (NOD) mice. Methods: NOD mice (n = 75, 7\u201321 weeks old) were injected intravenously with [111In]\u00adIn-DTPA-exendin-3, and single-photon emission computed tomography (SPECT) images were acquired 1 h pi. The pancreatic accumulation of [111In]\u00adIn-DTPA-exendin-3 was quantified in vivo using SPECT and by ex vivo counting and correlated to the \u03b2 cell mass (BCM). The influence of insulitis and hyperglycemia on the exendin uptake was assessed. Results: The pancreas could be visualized longitudinally using SPECT. A linear correlation was found between the BCM (%) and pancreatic uptake (%ID\/g) as measured by ex vivo counting (Pearson r = 0.64, p &amp;lt; 0.001), which was not affected by either insulitis (Pearson r = 0.66, p = 0.83) or hyperglycemia (Pearson r = 0.57, p = 0.51). Biodistribution and ex vivo autoradiography revealed remaining [111In]\u00adIn-DTPA-exendin-3 uptake in the pancreas despite total ablation of BCM. Conclusions: Despite hyperglycemia and severe insulitis, we have found a good correlation between BCM and pancreatic exendin uptake, even in a suboptimal model with relatively high background activity.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.9b00728","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T20:08:14Z","timestamp":1564085294000},"page":"4024-4030","source":"Crossref","is-referenced-by-count":16,"title":["Measuring the Pancreatic \u03b2 Cell Mass in Vivo\nwith Exendin SPECT during Hyperglycemia and Severe Insulitis"],"prefix":"10.1021","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-8664","authenticated-orcid":true,"given":"Lieke","family":"Joosten","sequence":"first","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Brom","sequence":"additional","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Peeters","sequence":"additional","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desire\u0301e","family":"Bos","sequence":"additional","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Himpe","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Brussel , , Laarbeeklaan 103 , ,","place":["Brussels, Belgium, B-1090"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bouwens","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Brussel , , Laarbeeklaan 103 , ,","place":["Brussels, Belgium, B-1090"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Boerman","sequence":"additional","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gotthardt","sequence":"additional","affiliation":[{"name":"Radboud university medical center , , PO Box 9101, ,","place":["Nijmegen, The Netherlands, 6500 HB"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"2026081717222150600_cit1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"2026081717222150600_cit2","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production\nand pancreatic ss-cell turnover after 50 years of diabetes: Joslin\nMedalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"2026081717222150600_cit3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained\nbeta cell apoptosis in patients with long-standing type 1 diabetes:\nindirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"key":"2026081717222150600_cit4","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00125-013-3043-5","article-title":"The diagnosis of insulitis\nin human type 1 diabetes","volume":"56","author":"Campbell-Thompson","year":"2013","journal-title":"Diabetologia"},{"key":"2026081717222150600_cit5","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.2337\/db07-0416","article-title":"Screening for insulitis\nin adult autoantibody-positive organ donors","volume":"56","author":"In\u2019t\nVeld","year":"2007","journal-title":"Diabetes"},{"key":"2026081717222150600_cit6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"2026081717222150600_cit7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","article-title":"Beta cells\nin type 1 diabetes: mass\nand function; sleeping or dead?","volume":"62","author":"Oram","year":"2019","journal-title":"Diabetologia"},{"key":"2026081717222150600_cit8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00125-014-3166-3","article-title":"Non-invasive quantification\nof the beta cell mass by SPECT with (1)(1)(1)\u00adIn-labelled exendin","volume":"57","author":"Brom","year":"2014","journal-title":"Diabetologia"},{"key":"2026081717222150600_cit9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2967\/jnumed.112.114066","article-title":"In vivo imaging of the\nglucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled\nDO3A-exendin-4","volume":"54","author":"Selvaraju","year":"2013","journal-title":"J Nucl. Med."},{"key":"2026081717222150600_cit10","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2337\/db17-1312","article-title":"Validation\nof (111)\u00adIn-Exendin\nSPECT for the Determination of the beta-Cell Mass in BioBreeding Diabetes-Prone\nRats","volume":"67","author":"Brom","year":"2018","journal-title":"Diabetes"},{"key":"2026081717222150600_cit11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/db09-1159","article-title":"Cytokines interleukin-1\nbeta and tumor necrosis factor-alpha regulate different transcriptional\nand alternative splicing networks in primary beta-cells","volume":"59","author":"Ortis","year":"2010","journal-title":"Diabetes"},{"key":"2026081717222150600_cit12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molmet.2015.01.010","article-title":"Chronic hyperglycemia\ndownregulates GLP-1 receptor signaling in pancreatic beta-cells via\nprotein kinase A","volume":"4","author":"Rajan","year":"2015","journal-title":"Mol. Metab."},{"key":"2026081717222150600_cit13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2337\/db06-1033","article-title":"Downregulation of GLP-1\nand GIP receptor expression by hyperglycemia: possible contribution\nto impaired incretin effects in diabetes","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"key":"2026081717222150600_cit14","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2915","article-title":"Animal models\nof human type 1 diabetes for evaluating combination therapies and\nsuccessful translation to the patient with type 1 diabetes","volume":"33","author":"Lenzen","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2026081717222150600_cit15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1242\/dmm.004705","article-title":"Sweetness\nand light: perspectives for rodent models of type 1 diabetes","volume":"3","author":"Avner","year":"2010","journal-title":"Dis. Models Mech."},{"key":"2026081717222150600_cit16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00125-013-3125-4","article-title":"Islet infiltration,\ncytokine expression and beta cell death in the NOD mouse, BB rat,\nKomeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes","volume":"57","author":"Jo\u0308rns","year":"2014","journal-title":"Diabetologia"},{"key":"2026081717222150600_cit17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/435481","article-title":"Prevention and Reversal\nof Diabetes by All-Trans Retinoid\nAcid and Exendin-4 in NOD Mice","volume":"2014","author":"Juang","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"2026081717222150600_cit18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cmmi.475","article-title":"Radiolabelled GLP-1 analogues for in vivo targeting\nof insulinomas","volume":"7","author":"Brom","year":"2012","journal-title":"Contrast Media Mol. Imaging"},{"key":"2026081717222150600_cit19","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-016-0221-8","article-title":"The effect of purification of Ga-68-labeled exendin\non in vivo distribution","volume":"6","author":"Brom","year":"2016","journal-title":"EJNMMI Res."},{"key":"2026081717222150600_cit20","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/mnfr.201400211","article-title":"Phenylpropenoic\nacid\nglucoside augments pancreatic beta cell mass in high-fat diet-fed\nmice and protects beta cells from ER stress-induced apoptosis","volume":"58","author":"Mathijs","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"2026081717222150600_cit21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/isl.3.4.15728","article-title":"Insulitis in human type 1 diabetes: The quest for an elusive lesion","volume":"3","author":"In\u2019t\nVeld","year":"2011","journal-title":"Islets"},{"key":"2026081717222150600_cit22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11307-016-0936-y","article-title":"Strain Differences Determine\nthe Suitability of Animal Models for Noninvasive In Vivo Beta Cell\nMass Determination with Radiolabeled Exendin","volume":"18","author":"Willekens","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"2026081717222150600_cit23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00592-017-1046-2","article-title":"Species differences\nin pancreatic binding of DO3A-VS-Cys(40)-Exendin4","volume":"54","author":"Eriksson","year":"2017","journal-title":"Acta Diabetol."},{"key":"2026081717222150600_cit24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.diabres.2005.04.008","article-title":"An autoradiographic\nstudy of [(18)\u00adF]\u00adFDG uptake to islets of Langerhans in NOD mouse","volume":"70","author":"Kalliokoski","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2026081717222150600_cit25","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/371716","article-title":"Radioiodinated\nnaphthylalanine derivatives targeting\npancreatic beta cells in normal and nonobese diabetic mice","volume":"2008","author":"Amartey","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"2026081717222150600_cit26","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.2337\/db05-1034","article-title":"Effects of autoimmunity\nand immune therapy on beta-cell\nturnover in type 1 diabetes","volume":"55","author":"Sherry","year":"2006","journal-title":"Diabetes"},{"key":"2026081717222150600_cit27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2213-8587(18)30112-8","article-title":"The challenge\nof modulating beta-cell autoimmunity in type 1 diabetes","volume":"7","author":"Atkinson","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2026081717222150600_cit28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2018.12.003","article-title":"Advances in\nimmunotherapy of type I diabetes","volume":"139","author":"Ni","year":"2019","journal-title":"Adv. Drug\nDelivery Rev."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.9b00728","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/9\/4024\/13581828\/mp9b00728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/9\/4024\/13581828\/mp9b00728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:35:34Z","timestamp":1787002534000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/16\/9\/4024\/507302\/Measuring-the-Pancreatic-Cell-Mass-in-Vivo-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,7,25]]},"published-print":{"date-parts":[[2019,9,3]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00728","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}